Cytokinetics Inc (CYTK)

Cytokinetics Inc (CYTK) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $8.5B; returns 1 day -1.8%, 1 week -1.2%, 1 year +6.5%.

Cytokinetics Inc. is a specialty cardiovascular biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors for diseases characterized by compromised muscle function. As of January 2026, the company has transitioned into a commercial-stage entity following the U.S.

Groups CYTK belongs to

• Biotechnology
• Biopharmaceutical
• Cardiovascular Therapies
• Healthcare
• Pharmaceuticals
• Commercial Stage Biotech
• Life Sciences
• Unmet Medical Needs
• Precision Medicine

CYTK financial model: income statement, cash flow and balance sheet